Details for New Drug Application (NDA): 205005
✉ Email this page to a colleague
The generic ingredient in NITROFURANTOIN is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.
Summary for 205005
Tradename: | NITROFURANTOIN |
Applicant: | Zydus Pharms |
Ingredient: | nitrofurantoin, macrocrystalline |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 205005
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NITROFURANTOIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 205005 | ANDA | Major Pharmaceuticals | 0904-7026 | 0904-7026-61 | 100 BLISTER PACK in 1 CARTON (0904-7026-61) / 1 CAPSULE in 1 BLISTER PACK |
NITROFURANTOIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 205005 | ANDA | Zydus Pharmaceuticals (USA) Inc. | 68382-559 | 68382-559-01 | 100 CAPSULE in 1 BOTTLE (68382-559-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Dec 12, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Dec 12, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription